JP2006528644A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528644A5
JP2006528644A5 JP2006521297A JP2006521297A JP2006528644A5 JP 2006528644 A5 JP2006528644 A5 JP 2006528644A5 JP 2006521297 A JP2006521297 A JP 2006521297A JP 2006521297 A JP2006521297 A JP 2006521297A JP 2006528644 A5 JP2006528644 A5 JP 2006528644A5
Authority
JP
Japan
Prior art keywords
stabilizer
oxidation state
water
cysteine
radiopharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521297A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528644A (ja
JP5139678B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/023930 external-priority patent/WO2005009393A2/en
Publication of JP2006528644A publication Critical patent/JP2006528644A/ja
Publication of JP2006528644A5 publication Critical patent/JP2006528644A5/ja
Application granted granted Critical
Publication of JP5139678B2 publication Critical patent/JP5139678B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521297A 2003-07-24 2004-07-23 安定な放射性医薬品組成物およびその製法 Expired - Fee Related JP5139678B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48985003P 2003-07-24 2003-07-24
US60/489,850 2003-07-24
PCT/US2004/023930 WO2005009393A2 (en) 2003-07-24 2004-07-23 Stable radiopharmaceutical compositions and methods for preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012102165A Division JP2012158600A (ja) 2003-07-24 2012-04-27 安定な放射性医薬品組成物およびその製法

Publications (3)

Publication Number Publication Date
JP2006528644A JP2006528644A (ja) 2006-12-21
JP2006528644A5 true JP2006528644A5 (https=) 2009-12-10
JP5139678B2 JP5139678B2 (ja) 2013-02-06

Family

ID=34102942

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006521297A Expired - Fee Related JP5139678B2 (ja) 2003-07-24 2004-07-23 安定な放射性医薬品組成物およびその製法
JP2012102165A Withdrawn JP2012158600A (ja) 2003-07-24 2012-04-27 安定な放射性医薬品組成物およびその製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012102165A Withdrawn JP2012158600A (ja) 2003-07-24 2012-04-27 安定な放射性医薬品組成物およびその製法

Country Status (13)

Country Link
US (3) US20070269375A1 (https=)
EP (1) EP1654005A4 (https=)
JP (2) JP5139678B2 (https=)
KR (1) KR101106533B1 (https=)
CN (1) CN100418585C (https=)
AU (1) AU2004259028C1 (https=)
BR (1) BRPI0412824A (https=)
CA (2) CA2526556C (https=)
IL (1) IL172059A0 (https=)
RU (1) RU2006105644A (https=)
SG (2) SG177216A1 (https=)
WO (1) WO2005009393A2 (https=)
ZA (1) ZA200509666B (https=)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
WO2007008232A2 (en) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
GB0514087D0 (en) 2005-07-11 2005-08-17 Ge Healthcare Ltd Stabilised radiopharmaceutical compositions
EP1940841B9 (fr) 2005-10-07 2017-04-19 Guerbet Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
FR2891830B1 (fr) 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
WO2008056481A1 (en) * 2006-11-09 2008-05-15 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
WO2008088658A2 (en) * 2007-01-17 2008-07-24 Immunomedics, Inc. Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
EP2170268A2 (en) 2007-06-25 2010-04-07 Amgen, Inc. Compositions of specific binding agents to hepatocyte growth factor
RU2474435C2 (ru) * 2007-11-07 2013-02-10 Джи-И Хелткер БВ Стабилизация радиофармацевтических композиций
AU2009220244B2 (en) 2008-02-29 2014-10-09 Lantheus Medical Imaging, Inc. Contrast agents for applications including perfusion imaging
EP2100900A1 (en) * 2008-03-07 2009-09-16 Universitätsspital Basel Bombesin analog peptide antagonist conjugates
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
US20120045393A1 (en) 2009-03-17 2012-02-23 Linder Karen E Lhrh-ii peptide analogs
WO2010121133A2 (en) 2009-04-17 2010-10-21 The General Hospital Corporation Multimodal imaging of fibrin
EP2408790A1 (en) 2009-03-19 2012-01-25 Wyeth LLC Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid and precursors thereof
KR101602992B1 (ko) * 2009-04-15 2016-03-11 랜티우스 메디컬 이메징, 인크. 아스코르브산을 사용한 방사성 약제 조성물의 안정화
WO2011066521A2 (en) 2009-11-30 2011-06-03 Stc. Unm Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
WO2011078250A1 (ja) * 2009-12-25 2011-06-30 独立行政法人理化学研究所 生体内にて標的組織に指向する放射標識化合物およびその利用
CN102858752B (zh) 2010-02-08 2018-10-16 兰休斯医疗成像公司 用于合成显像剂和其中间体的方法和装置
CN101786990B (zh) * 2010-03-04 2012-01-18 合肥工业大学 一种具有抗痒活性的化合物
US9240253B2 (en) * 2010-04-07 2016-01-19 Ge-Hitachi Nuclear Energy Americas Llc Column geometry to maximize elution efficiencies for molybdenum-99
DE102010026060A1 (de) * 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines Tumors, der einen Somatostatinrezeptor exprimiert
DE102010026065A1 (de) * 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines Tumors, der einen Bombesin-Rezeptor exprimiert
DE102010026052A1 (de) * 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines krankhaften Gewebes, das einen IGF-Rezeptor exprimiert
ES2785990T3 (es) 2010-08-13 2020-10-08 Siemens Medical Solutions Usa Inc Formulación, aparato y método para estabilizar productos radiofarmacéuticos
ITFI20110180A1 (it) * 2011-08-12 2013-02-13 Advanced Accelerator Applic S A Processo per la preparazione di complessi di 68ga.
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
KR101973830B1 (ko) * 2011-12-21 2019-04-29 아이소테라퓨틱스 그룹 엘엘씨 방사성 조성물 및 그의 치료적 사용 방법
KR20140102700A (ko) * 2011-12-21 2014-08-22 지이 헬쓰케어 리미티드 시트레이트 완충제 내 18ｆ―플루시클로빈 조성물
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
CN102552949B (zh) * 2012-02-21 2013-07-10 安徽筑梦生物科技有限公司 99mTc标记RGD多肽肿瘤诊断药物及其制备方法
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
EP2895204B1 (en) * 2012-09-13 2020-10-21 Provincial Health Services Authority Compositions targeting bradykinin receptor b1 for medical imaging of cancer and other disorders
PL2900279T3 (pl) * 2012-09-25 2020-05-18 Advanced Accelerator Applications Usa, Inc. Antagonisty grpr do wykrywania, diagnostyki i leczenia raka grpr-pozytywnego
RU2528414C1 (ru) 2013-01-25 2014-09-20 Закрытое Акционерное Общество "Фарм-Синтез" Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
EP2821383B1 (en) * 2013-07-02 2017-08-30 Trasis S.A. Stabilization of radiosynthetic intermediates
JP6410339B2 (ja) * 2013-03-25 2018-10-24 国立大学法人千葉大学 放射性核種標識オクトレオチド誘導体
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
KR101523249B1 (ko) * 2014-05-22 2015-05-27 서울대학교산학협력단 엑소좀을 방사성 물질로 표지하는 방법 및 그 용도
KR101658201B1 (ko) * 2014-06-16 2016-09-22 한국원자력연구원 전립선암의 진단 및 치료를 위한 가스트린유리펩티드수용체 작용서열 기반의 신규한 봄베신 유도체 화합물
US10227376B2 (en) * 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
BE1021191B1 (fr) 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
IL237525A (en) 2015-03-03 2017-05-29 Shalom Eli Method for labeling a prostate-specific membrane antigen with a radioactive isotope
JP6527736B2 (ja) * 2015-03-30 2019-06-05 富士フイルム富山化学株式会社 放射性医薬組成物
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10758634B2 (en) 2016-03-18 2020-09-01 Wake Forest University Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
CA3062538A1 (en) * 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
DK3459526T3 (da) * 2017-09-26 2021-05-25 Palacky Univ In Olomouc Biotilgængelige dithiocarbamat-metalkompleks-nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf
WO2019147912A1 (en) * 2018-01-26 2019-08-01 Wake Forest University Kit technology for the production and long-term storage of zr-89-pet radiopharmaceuticals
WO2019195890A1 (en) 2018-04-11 2019-10-17 Clarity Pharmaceuticals Pty Ltd Formulations and kits for radiotherapy and diagnostic imaging
US10596278B2 (en) * 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
TW202517302A (zh) 2018-07-25 2025-05-01 法商高級催化劑應用品有限公司 穩定的、濃縮的放射性核種錯合物溶液
WO2020021310A1 (en) * 2018-07-25 2020-01-30 Advanced Accelerator Applications (Italy) Srl Stable, concentrated radionuclide complex solutions
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
DK4541379T3 (da) * 2018-07-25 2026-02-02 Advanced Accelerator Applications S A Stabile koncentrerede radionuklidkompleksopløsninger
CN113766952B (zh) * 2019-03-29 2023-09-08 国立研究开发法人量子科学技术研究开发机构 放射性药品的制造方法及放射性药品
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
CN114728088A (zh) * 2019-09-16 2022-07-08 诺华股份有限公司 稳定的浓缩的放射性药物组合物
TWI878344B (zh) * 2019-09-17 2025-04-01 瑞士商諾華公司 放射性標記grpr拮抗劑之方法及其套組
KR102207372B1 (ko) * 2020-03-31 2021-01-27 재단법인 아산사회복지재단 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
KR20240004205A (ko) 2020-07-13 2024-01-11 포인트 바이오파마 인코포레이티드 방사성의약 및 방법
US11129912B1 (en) * 2020-07-13 2021-09-28 POINT Biopharma Inc. Radiopharmaceutical and methods
CN116547007A (zh) * 2020-07-13 2023-08-04 普安生物制药有限公司 放射性药物和方法
EP4204011A4 (en) 2020-08-27 2025-06-18 Centre for Probe Development And Commercialization (CPDC) Radiopharmaceutical and methods
CN116472068A (zh) * 2020-10-14 2023-07-21 癌症医学与细胞生物学世纪研究院 治疗性放射性标记的缀合物及其在疗法中的用途
WO2022111800A1 (en) * 2020-11-25 2022-06-02 Itm Solucin Gmbh Stable formulations for radionuclide complexes
CN112546247A (zh) * 2020-12-03 2021-03-26 西南医科大学附属医院 多羟基苯酚类化合物的应用、放射性药物组合物及制法
WO2022156907A1 (en) 2021-01-25 2022-07-28 Vrije Universiteit Brussel Method and kit for labeling a biomolecule with one or more detectable labels, including a radiolabel
BE1027699B1 (fr) * 2021-01-28 2022-04-01 Trasis S A Procédé de purification de macro-agrégats de sérumalbumine humaine radiomarqués
CN112999369B (zh) * 2021-03-03 2022-02-25 江苏元本生物科技有限公司 一种her2亲合体放射性核素标记物组合物及其应用
WO2022251516A2 (en) * 2021-05-26 2022-12-01 Cornell University Complexes with acyclic chelators and their use in targeted radiotherapy of cancer
KR20240053674A (ko) * 2021-08-02 2024-04-24 레이즈바이오, 인크. 방사성 핵종의 안정화된 조성물 및 이의 용도
WO2023100852A1 (ja) * 2021-11-30 2023-06-08 日本メジフィジックス株式会社 安定化放射性医薬組成物
CN116920129A (zh) * 2022-04-02 2023-10-24 北京先通国际医药科技股份有限公司 放射性药物水溶液及其制备方法和用途
CN116920128A (zh) * 2022-04-02 2023-10-24 北京先通国际医药科技股份有限公司 一种放射性药物水溶液及其用途
CN115015441B (zh) * 2022-07-14 2023-08-18 原子高科股份有限公司 一种测定镥[177Lu]氧奥曲肽注射液中稳定剂含量的方法
CA3263646A1 (en) * 2022-07-29 2024-07-18 Curium Us Llc [177lu] lutetium-psma l&t composition, kit, method of making, and method of using thereof
AU2024317528A1 (en) 2023-07-31 2026-03-05 Curium Us Llc [177 lu] lutetium-psma it composition and dosimetry, kit, method of making, and method of using thereof
WO2026008525A1 (en) * 2024-07-01 2026-01-08 Bayer Aktiengesellschaft Stable radionuclide-containing formulations

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US441181A (en) * 1890-11-25 Making peptonized meat
US441184A (en) * 1890-11-25 Car-coupling
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
US4416865A (en) * 1973-02-20 1983-11-22 Research Corporation Radiopharmaceuticals for localization of thromboembolic disease
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents
US4075314A (en) * 1976-04-29 1978-02-21 Mallinckrodt, Inc. Stannous pyrophosphate technetium-99m compositions
US4232000A (en) * 1978-06-28 1980-11-04 The Procter & Gamble Company Radioactive scanning agents with stabilizer
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
JPS57188527A (en) * 1981-04-21 1982-11-19 Amersham Int Plc Diagnosis of kidney function
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
DE78642T1 (de) * 1981-10-30 1983-10-27 Amersham International Plc, Amersham, Buckinghamshire Radiopharmazeutische zubereitung auf grund von technetium-99m und reagenz zur herstellung derselben.
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
US4510125A (en) * 1982-12-08 1985-04-09 Mallinckrodt, Inc. Process for making lyophilized radiographic imaging kit
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4652440A (en) * 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
MX174467B (es) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
US4935222A (en) * 1986-06-13 1990-06-19 University Of Cincinnati Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
US4808705A (en) * 1986-12-19 1989-02-28 Cetus Corporation Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5021556A (en) * 1987-07-22 1991-06-04 Neorx Corporation Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
US5128119A (en) * 1989-06-12 1992-07-07 Immunomedics, Inc. Methods for technetium/rhenium labeling of f(ab1)2 fragments
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5169933A (en) * 1988-08-15 1992-12-08 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
AU626348B2 (en) * 1988-10-14 1992-07-30 Mallinckrodt, Inc. Radiolabelled particulate composition
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5262175A (en) * 1989-05-10 1993-11-16 Solanki Kishor K Stabilization of radiopharmaceutical compositions
US5118797A (en) * 1989-08-28 1992-06-02 E. R. Squibb & Sons, Inc. Rhenium tris dioxime complexes
CA2034042C (en) * 1990-01-18 1999-08-17 Adrian D. Nunn Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
US5183653A (en) * 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
GB9019195D0 (en) * 1990-09-03 1990-10-17 Shell Int Research Cyclohexenol derivatives
JP2860157B2 (ja) * 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
DK0600992T3 (da) * 1991-08-29 2000-10-09 Mallinckrodt Medical Inc Anvendelse af gentissyre eller gentisylalkohol til stabilisering af radiomærkede peptider og proteiner
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
US5750088A (en) * 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US6066309A (en) * 1996-02-02 2000-05-23 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US6027710A (en) * 1996-09-18 2000-02-22 Nihon Medi-Physiscs Co., Ltd. Radiation-protecting agent
CA2283854A1 (en) * 1997-04-22 1998-10-29 The Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
CA2346154A1 (en) * 2001-05-02 2002-11-02 University Of Missouri Gastrin receptor-avid peptide conjugates
US5886142A (en) * 1997-05-20 1999-03-23 Thomas Jefferson University Radiolabeled thrombus imaging agents
WO1999008709A1 (fr) * 1997-08-14 1999-02-25 Daiichi Radioisotope Laboratories, Ltd. Medicament radioactif stable
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
GB0015242D0 (en) * 2000-06-22 2000-08-16 Nycomed Amersham Plc Stabiliser for radiopharmaceuticals
CA2413538A1 (en) * 2000-07-06 2002-01-17 Bristol-Myers Squibb Pharma Company Stable radiopharmaceutical compositions and methods for preparation thereof
ES2315295T3 (es) * 2000-07-28 2009-04-01 Nihon Medi-Physics Co., Ltd. Radiofarmaco para obtencion de imagenes diagnosticas que contiene un heterocomplejo de nitruro de tecnecio-99m.
US6989138B2 (en) * 2000-10-24 2006-01-24 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
FR2817259B1 (fr) * 2000-11-29 2003-02-21 Cis Bio Int Compose de chelation d'un metal, radiopharmaceutique, procede de fabrication de ceux-ci et trousse de diagnostic
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
CN100471523C (zh) * 2002-05-03 2009-03-25 伯拉考成像股份公司 放射性药物制剂
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds

Similar Documents

Publication Publication Date Title
JP2006528644A5 (https=)
CA2526556A1 (en) Stable radiopharmaceutical compositions and methods for their preparation
JP7079355B2 (ja) Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法
Sadler et al. The chemistry of gold drugs
JP2004529884A5 (https=)
AU2009221204C1 (en) Bombesin analog peptide antagonist conjugates
ES2624626T3 (es) Ligadores basados en tirosina para la conexión desprendible de péptidos
US7045503B1 (en) Radiometal-binding peptide analogues
JP3054346B2 (ja) ペプチド類
HU219336B (en) Process for producing peptide derivatives and pharmaceutical compositions comprising such compounds and diagnostic unit containing such compounds
JP2024542592A (ja) 細胞表面受容体を標的とする開裂可能放射性リガンド及びその使用
AU2003239351B2 (en) Radiopharmaceutical formulations
JP2014500883A (ja) 放射性コンジュゲーション方法
CA3148288A1 (en) Method for producing radioactive metal complex
US20090062509A1 (en) Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines
AU698824B2 (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
HUT73489A (en) Chelators of type xn1s1x' braked with twovalent calcogene atom for radioactive isotopes, their metal complexes and their diagnostic and therpeutical uses, and pharmaceutical compositions containing them, and process for producing them
KR20210121959A (ko) 혈전영상을 위한 방사성의약품 및 조성물
KR100567001B1 (ko) 시스테인 유도체 및 이를 이용한 금속 트리카보닐 착화물,이들의 제조 방법 및 이들을 포함하는 조영제
RU2006126637A (ru) Улучшенные производные пептида, высвобождающего гастрит